Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5346)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2021 (publication date) through Mar 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Alzamzamy A, Elsayed H, Abd Elraouf M, Eltoukhy H, Megahed T, Aboubakr A. Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients. World J Gastrointest Oncol 2021; 13(6): 600-611 [PMID: 34163576 DOI: 10.4251/wjgo.v13.i6.600] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i6/600.htm |
| Number | Citing Articles |
| 1 |
Rina Masadah, Andriany Qanitha, Rif'at Hanifah, Muhammad Azka Al Atsari, Andi Nurdahlia, Faturrahman Muiz, Rezky Aulia Yusuf. The potential role of Vascular Endothelial Growth Factor for hepatocellular carcinoma screening: a systematic review. F1000Research 2024; 13: 749 doi: 10.12688/f1000research.145606.1
|
| 2 |
Amro M Hassan, Heba H Orabi, Muhammad Abdel-Gawad , Omran Mohamed, Safwat S Sawy, Mona M Abdelmeguid, Mohamed A Bashir, Emad Abdelrazzak, Khalid Ead, Mustafa A Haridy. Changes in Vascular Endothelial Growth Factor and Development of Hepatocellular Carcinoma in Direct-Acting Antiviral Drugs (DAAs)-Treated Hepatocellular Carcinoma (HCC) Patients. Cureus 2024; doi: 10.7759/cureus.75982
|
| 3 |
Pritam Bhagwan Bhosale, Abuyaseer Abusaliya, Hun Hwan Kim, Vetrivel Preethi, Se Hyo Jeong, Min Yeong Park, Chung Kil Won, Jeong Doo Heo, Meejung Ahn, Je Kyung Seong, Gon Sup Kim. Comprehensive analysis of Apigetrin's effects on liver cancer cells: Insights from bioinformatics, in vitro studies, and next-generation transcriptome sequencing. Molecular and Cellular Probes 2025; 79: 102012 doi: 10.1016/j.mcp.2025.102012
|
| 4 |
Liming Zheng, Zeyu Huang, Xiaoping Li, Meifang He, Xiaoqin Liu, Guojun Zheng, Xike Zhou, Longgen Liu. Construction and validation of a predictive model for hepatocellular carcinoma based on serum markers. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02489-2
|
| 5 |
Moe Matsumoto, Hidenao Noritake, Maho Yamashita, Tomohiko Hanaoka, Masahiro Umemura, Kensuke Kitsugi, Shingo Takatori, Kazuyoshi Ohta, Jun Ito, Takeshi Chida, Kazuhito Kawata. A case of hepatitis B virus-infected patient with bevacizumab-related severe intratumor hemorrhage of large hepatocellular carcinoma (HCC). Kanzo 2023; 64(8): 382 doi: 10.2957/kanzo.64.382
|
| 6 |
Deniz Can Guven, Enes Erul, Taha Koray Sahin, Omer Dizdar, Suayib Yalcin, Ibrahim Halil Sahin. The Benefit of Immunotherapy in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Future Oncology 2022; 18(37): 4119 doi: 10.2217/fon-2022-0642
|
| 7 |
Rei Okada, Yuichiro Otsuka, Yoji Kajiwara, Tetsuya Maeda, Jun Ishii, Kazutaka Kimura, Yu Matsumoto, Yuko Ito, Kimihiko Funahashi, Hideaki Shimada. Prognostic and diagnostic effects of high serum midkine levels in patients with hepatocellular carcinoma. Oncology Letters 2024; 27(6) doi: 10.3892/ol.2024.14416
|